red-green, or mixed axis was present, the defect was noted as mild if the score was within the mean + 2 SD for that age and as severe if greater than that.'4 A separate series of ten consecutive stable sickle cell patients matched for age who were not given nifedipine were used as controls. These patients, who constituted the "nonsimultaneous" controls, were subjected to repeat hematologic and ophthalmologic assessments at intervals similar to the treatment group. Because of the design of this exploratory study, the investigators knew whether the patient was or was not being treated with nifedipine. 
